Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?

Autor: Kusejko K; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Neofytos D; Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland., van Delden C; Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland., Hirsch HH; Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.; Clinical Virology, Laboratory Medicine/Infectious Diseases, and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Meylan P; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Boggian K; Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal Hospital of St Gallen, St Gallen, Switzerland., Hirzel C; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Garzoni C; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Internal Medicine, Clinica Luganese Moncucco, Lugano, Switzerland., Sidler D; Division of Nephrology and Hypertension, Inselspital, Bern University Hospital, Bern, Switzerland., Schnyder A; Clinic for Nephrology, Cantonal Hospital of St Gallen, St Gallen, Switzerland., Schaub S; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland., Golshayan D; Transplantation Center, Lausanne University Hospital, Lausanne, Switzerland., Haidar F; Division of Nephrology, Department of Medicine, University Hospital of Geneva, Geneva, Switzerland., Bonani M; Division of Nephrology, University Hospital Zurich, Zurich, Switzerland., Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Mueller NJ; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland., Schreiber PW; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Jazyk: angličtina
Zdroj: Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 06; Vol. 11 (3), pp. ofae055. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
DOI: 10.1093/ofid/ofae055
Abstrakt: Background: Infectious diseases (IDs) are highly relevant after solid organ transplantation in terms of morbidity and mortality, being among the most common causes of death. Patients undergoing kidney retransplantation (re-K-Tx) have been already receiving immunosuppressive therapy over a prolonged period, potentially facilitating subsequent infections. Comparing ID events after re-K-Tx and first kidney transplantation (f-K-Tx) can delineate patterns and risks of ID events associated with prolonged immunosuppression.
Methods: We included adult patients with records on f-K-Tx and re-K-Tx in the Swiss Transplant Cohort Study. We analyzed ID events after f-K-Tx and re-K-Tx within the same patients and compared infection rates, causative pathogens, and infection sites. Recurrent time-to-event analyses were performed for comparison of infection rates.
Results: A total of 59 patients with a median age of 47 years (range, 18-73) were included. Overall, 312 ID events in 52 patients occurred. In multivariable recurrent event modeling, the rate of ID events was significantly lower after re-K-Tx (hazard ratio, 0.70; P = .02). More bacterial (68.9% vs 60.4%) and fungal (4.0% vs 1.1%) infections were observed after f-K-Tx but fewer viral infections (27.0% vs 38.5%) as compared with re-K-Tx ( P = .11). After f-K-Tx, urinary and gastrointestinal tract infections were more frequent; after re-K-Tx, respiratory tract and surgical site infections were more frequent ( P < .001).
Conclusions: ID events were less frequent after re-K-Tx. Affected sites differed significantly after f-K-Tx vs re-K-Tx.
Competing Interests: Potential conflicts of interest. P. W. S. received travel grants from Pfizer and Gilead, speaker's honorary from Pfizer, and fees for advisory board activity from Pfizer and Gilead outside the submitted work. All other authors report no potential conflicts.
(© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje